Treatment of Drug-Susceptible Tuberculosis

Abstract

Mycobacterium tuberculosis is a major public health concern and requires prompt treatment. Goals of treatment include curing the individual patient and protecting the community from ongoing tuberculosis transmission. To achieve durable cure, regimens must include multiple agents given concurrently and in a manner to ensure completion of therapy. This article focuses on preferred regimens of drug-susceptible tuberculosis under current guidelines by the American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America and World Health Organization. In addition, topics including patient centered care, poor treatment outcomes, and adverse effects are also discussed.

Keywords: Drug-susceptible Mycobacterium tuberculosis; HIV and Mycobacterium tuberculosis co-infection; M tuberculosis treatment supervision and patient-centered care; Mycobacterium tuberculosis treatment regimen.